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ABSTRACT 
 
Background: Coronary Heart Disease is a big concern for the health of the residents of India. Environmental 
contaminants, air pollutants, synthetic chemicals, and the mineral content in drinking water can affect the 
heart  by  altering  the  heart  rate,  contractility  and  excitability  of  heart  muscle  or  by  causing 
atherosclerosis. Objective: The aim of this study is to observe the level of arsenic exposure and clastogenic 
effect of arsenic in coronary heart disease cases of West Bengal. Methods: A total 511 cases were screened. 
Our study group included 100 nos of coronary heart disease cases and 70 no of healthy controls from West 
Bengal.  Multivariate  Logistic  Regression  and  Student’s  t  -  test  was  used  for  statistical  analysis  of  the 
parameters. The clastogenic  effect of  Arsenic was  also examined by performing  Cytogenetic Analysis. 
Results: Multivariate logistic regression analysis has revealed that a patient’s age, Low density lipoprotein 
level and hypertension played a significant role in the development of CHD. Hair arsenic level in CHD 
cases (0.7±0.2) µg/kg was significantly high (p<0.01) than that of the controls (0.20±0.09) µg/kg. Mitotic 
index (4.4±0.21) was significantly low (p≤0. 05) and chromosomal aberration (0.61±0.13) was significantly 
higher  (p≤0.  005)  in  CHD  cases.  Conclusion:  This  study  has  revealed  the  facts  that  age,  low  density 
lipoprotein level, hypertension are the three significant risk factors of CHD. It was found that, the hair 
arsenic content of the CHD cases in this region was having the arsenic body burden. Clastogenic effect of 
arsenic on coronary heart disease cases. 
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INTRODUCTION  
 
Cardiovascular  disease  is  the  leading  cause  of 
mortality worldwide
1 .Atherosclerosis is the most 
common form of cardiovascular disease; it usually 
manifests clinically as the coronary artery disease,  
 
peripheral arterial disease. The major risk factors 
are  smoking,  alcohol  intake,  hyperlipidemia, 
diabetes,  hypertension,  obesity,  positive  family 
history.  Unhealthy  diet,  sedentary  and  stressful 
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lifestyle, environmental pollution are taking a toll 
on  the  heart  health  of  millions  of  Indians.  High 
level  of  low  density  lipoprotein  (LDL)  increases 
the  risk  of  coronary  heart  disease  (CHD)  by 
narrowing or blocking arteries which carry blood 
to  the  heart.  Increased  levels  of  high  density 
lipoprotein lower the risk of CHD. High levels of 
triglycerides  which  make  up  a  large  part  of  the 
body’s fat and also found in the blood stream are 
also associated with the increasing risk of CHD
2. 
There  are  some  environmental  factors  like  air 
pollution, presence of synthetic chemicals, heavy 
metals  and  pharmaceuticals  that  cause  or 
exacerbate  preexisting  cardiovascular  disease
3.  
Arsenic  content  in drinking  water  can  affect  the 
heart since it enhances the atheroma formation by 
involving  cholesterol  metabolism  and  favoring 
fatty deposition beneath the surface of endothelial 
cells  lining  of  the  arterial  wall,  which  causes 
atherosclerosis
4, 5. Long term exposure to inorganic 
arsenic is a risk factor for cardiovascular disease
6,7. 
Arsenic  increases  the  production  of  reactive 
oxygen which has been identified as the initial step 
towards  the  arsenic  induced  endothelial  cell 
proliferation
8. Arsenic increases the level of lipid 
peroxides  and  super  oxide  radicals  in  blood
9,  10. 
Arsenic toxicity may alter the endothelial function 
and nitric oxide metabolism, resulting in decreased 
cell  growth
11,12.  Arterial  thrombosis  and  platelet 
aggregation  may  get  induced  by  arsenic 
toxicity
13,14.  Major  incidences  of  arsenic  toxicity 
have been found in Taiwan, Antofagasta in Chile, 
Mexico  and  Argentina
15.  The  contamination  of 
ground water with arsenic in West Bengal (W.B., 
India) has been recognized as a major public health 
hazard
16.  Total  nine  districts  of  W.B.  have  been 
identified as Arsenic affected areas. Approximately 
63% of total the population of W.B. reside in these 
areas. People living in these areas, are exposed to 
arsenic through drinking water and those who are 
not  from  these  areas  get  exposed  through  food 
composites
17. Several studies conducted around the 
world  have  reported  that  the  risk  factors  also 
depend  on  the  genetic  background  of  different 
ethnic groups
18. Arsenic has long been known to 
cause chromosomal damage, but most investigators 
have been unable to induce direct gene mutation
19. 
The  reports  on  the  arsenic exposure  of  coronary 
heart  disease  patients  of  West  Bengal  are  very 
limited. The clastogenic effect of arsenic on human 
cell  is  represented  in  this  study.  The  extent  of 
dependency  of  CHD  on  different  risk  factors  is 
also investigated. 
 
MATERIALS AND METHODS 
 
Study Subjects 
A  total  1011  cases  were  screened  for  this  study 
from cardiology OPD (Out Patients Department) of 
Ramakrishna Mission Seva Pratishthan. Out of the 
511 cases clinically diagnosed by the physician of 
cardiology  OPD,  100  cases  with  CHDs  were 
chosen  for  this  study.  The  studied  population 
belonged  to  ages  ranging  from  20  to  70  years. 
Patients  were  having  some  major  complaints  of 
Ischemic  heart  disease  (IHD),  Myocardial 
infarction (MI), Unstable angina (UA). Patients are 
not  having  any  congenital  heart  disease. 
Experienced cardiologist verified the diagnosis of 
these cardiac problems with the presence of at least 
two  of  the  following  criteria:  (i)  Characteristic 
chest  pain,  (ii)  elevated  cardiac  enzyme,  (iii) 
Electrocardiographic  changes.   Cases with minor 
complications  like  chest  pain  due  to  acidity, 
hypertension  without  any  cardiac  problem  and 
cases who came for routine check up before any 
surgery  were  excluded.  Those  patients  who  had 
renal  and  hepatic  insufficiency  and  those  were 
taking some hormonal drugs were excluded from 
this  study.  Cardiac  cases  were  divided  into  two 
groups according to drug intake. Out of 100 cases 
50  cases  were  under  statin  therapy  (group  A), 
remaining 50 cases were not under statin therapy 
(group B). In cardiology OPD, patients were from 
different districts of West Bengal and their main 
source of drinking water was either tube well water 
or well water. For the 58% of the cases, arsenic 
content in drinking water was above 10µg/L (the 
WHO guideline value) and for the remaining 42%, 
the same was above 50µg/L (the Indian standard 
value).  70 healthy  control  cases  were  from  non- 
arsenic  affected  area.  Seventy  populations  based 
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controls,  which  were  free  of  clinical  CHD 
(substantiated by 12 lead rest  ECG  and history), 
were included in the study. Moreover, the source 
of drinking water was also a criterion for selecting 
the  controls.  For  controls,  the  main  source  of 
drinking water was municipality supplied filtered 
water. 
Detailed  history  was  taken  from  all  cases  and 
control with the help of a questionnaire prepared as 
per  the  guidelines  of  the  World  Health 
Organization
20.  A  questionnaire,  which  included 
questions on lifestyle  factors (smoking), personal 
factors (age, sex, source of drinking water, family 
history of CHD etc.), health status (state of health, 
diabetic,  hypertensive),  was  filled-up.  Fasting 
blood glucose≥120mg/dl considered to be diabetic. 
Studied samples having systolic blood pressure of 
>160mmHg  and  diastolic  blood  pressure  of 
>90mmHg,  were  defined  as  hypertensive.    All 
patients  gave  their  written  consent  prior  to  the 
participation,  and  the  study  procedures  followed 
the  guidelines  of  the  Institutional  Ethical 
Committee. 
Lipid analysis 
Overnight  fasting  blood  was  collected  from  the 
patients  and  healthy  controls.  2-3ml  blood  was 
collected  from  each  patient.  Lipid  levels 
Triglycerides (TGL) by GPO-PAP method, Total 
Cholesterol  (T.Chol)  by  CHOD,  High  Density 
Lipoprotein  Cholesterol  (HDL-C),  level  were 
studied using AGAPPE (India) diagnostics kit with 
the  help  of  Johnson  &  Johnson  Vitros  Eci 
autoanalyser. Low Density Lipoprotein Cholesterol 
(LDL-C), Very Low Density Lipoprotein (VLDL) 
was calculated using the formula: 
VLDL=TGL/5, LDL= T.Chol-HDLC- VLDL. 
Short-term leukocyte cultures 
Short-term leucocyte culture was carried out by the 
method of Sharma and Taluklder
21. A total of 4ml 
of  peripheral  venous  blood  was  collected  from 
each donor under aseptic condition with the help of 
a  sterile  disposable  needle  and  transferred  to 
heparinized  vial.  For  each  subject,  duplicate 
cultures  were  maintained.  Leucocyte-rich  plasma 
(0.5ml) was added to 5ml of culture media (RPMI 
1640, Sigma, St. Louis, USA) supplemented with 
20%  fetal  bovine  serum  (Sigma)  and 
phytohemagglutinin  M  (0.04  mL/mL  of  culture 
media, GIBCO BRL). The cultures were incubated 
at 37
0C. At 70 hours of culture, colchicine (0.2mL 
of 0.04% mL) was added. Two hours later, cells 
were centrifuged  at 1000rpm  for  10  min,  treated 
with  pre-warmed  KCL  (0.075  M)  for  15  min, 
centrifuged at 1000 rpm for 10 min and fixed in 
methanol:  acetic  acid  (3:1).  The  fixed  cell 
suspension was laid on clean grease-free and glass 
slide  air-dried.  The preparation  was  stained  with 
aqueous Giemsa. All slides were coded and 1000 
blast  cells  were  scored  to  determine  the  mitotic 
index  per  individual  and  100  metaphase  plates 
were  scored  randomly  for  chromosomal 
aberrations (chromatid and chromosome types) per 
individual. 
Estimation of arsenic concentration 
Biological samples (hair and nails) were collected 
from both patients and controls. Before estimation, 
the hair and nail samples were digested with 5ml 
of concentrated nitric acid and 3ml of concentrated 
sulfuric  acid.  Flow  injection-hybrid  generation-
atomic  absorption  spectrometry  (FI-HG-AAS)  at 
327nm was used for estimation of arsenic in the 
collected biosamples. A Perkin-Elmer model 3100 
AAS  with  a  Hewlett-Packard-Vectra  386/25N 
computer with GEM software, Perkin-Elmer EDL 
System-2 and arsenic lamp (lamp current 400mA) 
were used for this purpose. 
Statistical analysis 
An  exhaustive  search  of  various  subsets  of 
explanatory variables (age, sex, family history of 
CHD,  hypertension,  diabetes,  smoking,  Total 
cholesterol,  triglyceride,  low  density  lipoprotein, 
high  density  lipoprotein,  very  low  density 
lipoprotein)  was  carried  out  in  the  cases 
corresponding to without statin group and control. 
The  stepwise  logistic  regression  analysis  was 
performed  with  the  SPSS  statistical  package 
(version  16)  to  determine  the  independent  risk 
factor  for  CHD.  Multivariate  logistic  regression 
was used to find the Odds Ratio (O.R.) and 95% CI 
was  used  to  assess  the  extent  of  risks  of 
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independent  variables  on  CHD.  Intergroup 
comparisons of risk factors were performed using 
analysis of variance. Student’s t test was also used 
for  other  parameters.  The  value  of  p<0.05  was 
considered as statistically significant. 
 
RESULTS  
The  mean  age  of  cardiac  cases  was  found 
50.06±1.25 years & control cases with 52.27±1.96 
years.    The baseline characteristic of  the sample 
population was described in Table 1. In CHD cases 
the percentage of male (79%) sample was higher 
than  women  (21%).  Frequency  of  smokers  was 
significantly higher (p<0.001) in the cardiac cases 
than  control.  Presence  of  past  family  history  of 
coronary  heart  disease  was  significantly  higher 
(p<0.01)  in  cardiac  cases  than  control.  The 
prevalence of hypertension (p<0.001) and diabetes 
(p<0.01) were also significantly higher in cardiac 
cases than control cases.  
In  Table  2,  a  different  set  of  biochemical 
parameters  was  compared  between  three  groups 
i.e. group A and group B vs. healthy control group. 
Total Cholesterol level of cardiac cases in both of 
the groups i.e. of group A (162.81±6.23) and group 
B  (204.79±10.47)  were  significantly  higher 
(p<0.005)  and  (p<0.0005)  respectively  than 
healthy  control  cases.  The  same  scenario  was 
repeated  for  triglyceride  level  of  Group  A 
(129.21±8.84)  &  Group  B  (218.63±9.24)  were 
significantly  higher  (p<0.05)  and  (p<0.0005) 
respectively  than  healthy  control  cases 
(149.14±8.818).  But  for  both  the  parameters,  a 
significance  level  of  group  B  was  higher  than 
group A while compared with controls. Level of 
low density lipoprotein was significantly higher in 
group  A  (99.65±4.86)  (p<0.0005)  and  group  B 
(142.33±4.77)  (p<0.0005)  than  healthy  control 
(78.52±2.50). On the other hand it was found that 
the  level  of  high  density  lipoprotein  was 
significantly higher in control cases (44.44±1.29) 
(p<0.001)  than  group  B  (37.30±0.612).  No 
significant difference was observed between group 
A and control cases. Very low density lipoprotein 
level  was  significantly  higher  in  control  cases 
(26.3±1.82) (p<0.02) than group A (21.10±0.216) 
but no significant difference was found in between 
group  B  (28.92±3.57)  and  control  cases. 
Multivariate logistic analysis was performed in 120 
cases  (cardiac  cases  group  B=50,  control 
cases=70). Of the different variables, age, LDL and 
hypertension remained in the final model. The final 
model is, 
Log (Probability of heart disease/Probability of no 
heart disease  = b0+b1×LDL+b2×Age+b3 × 
Hypertension  
According to the logistic model (Table 3), patients 
age  (p<  0.025),  LDL  level  (p<0.004)  and 
hypertension (p<0.019) played a significant role in 
the  development  of  CHD.  All  regression 
coefficients of independent variables were positive 
which  indicates  the  positive  relationship  of  risk 
factors with CHD. Age’s OR (1.166), showing that 
there  are  1.166  times  more  chances  to  have  the 
CHD with one year increases in age. An increase 
in  LDL  by  1µg/dl,  the  risk  of  heart  disease 
increases by an estimated factor by 1.358. In the 
presence  of  hypertension  there  are  41.596  times 
more  chances  to  get  the  disease  of  CHD.  The 
remaining explanatory variables do not contribute 
to the model significantly after taking into account 
the effects of LDL, age and hypertension. It may 
be due to low sample size. 
The arsenic level of biological sample of cardiac 
cases  was  compared  with  healthy  control.  There 
was  a  significant  (p<0.01)  differences  in  the 
amount  of  arsenic  content  in  cardiac  cases 
(0.7±0.2)  µg/kg  &  in  control  (0.2±0.09)  µg/kg 
(Table  4).  Mean  arsenic  content  of  different 
diagnosis cases like Ischemic Heart Disease (IHD), 
Myocardial  Infarction (MI)  and Unstable Angina 
(UA)  were  0.8±0.12µg/kg,  1.0±0.39µg/kg  and 
0.2±0.05µg/kg respectively (Table 5). 
The  mitotic indexx was  significantlyhigherh (p≤. 
.005) in healthy control than patient, it was 5±0.24. 
Chromosomal Aberration was significantly higher 
(p≤0. 05) in more patient than healthy control, it 
was 0.61±0.13 (Table 6). Mitotic index observed in 
Ischemic  Heart  Disease  (IHD)  was  4.4±0.29, 
Myocardial  Infarction  (MI)  was  4.3±0.3  and 
Unstable  Angina  (UA)  was  6.3±1.22. 
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Chromosomal  Aberration  of  IHD  &  MI  was  0.435±0.16 and 0.842±0.22 respectively (Table 7).
 
Table: 1. Baseline clinical characteristics of cardiac and control cases. 
 
 
 
 
 
 
 
 
 
 
 
 
p=calculated as a chi square test. NA= not applicable. 
 
Table: 2. An association of the Lipid profile of coronary heart disease cases with control cases. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
p=calculated as a chi square test. NS= Not Significant 
 
Table: 3. Variables in the equation 
Regression 
Coefficient 
Beta  Standard 
 Error 
95% confidence 
intervals (CI) 
p-value  Odds ratio 
(OR) 
bo  38.322  13.653  -  0.005  0.000 
b1  0.306  0.107  1.102-1.674  0.004  1.358 
b2  0.153  0.068  1.020-1.332  0.025  1.166 
b3  3.278  1.400  0.002-0.587  0.019  41.596 
Analysis comparing CHD risk factors among case and control subjects 
  Case(n=100)  p value  Control (n=70) 
Age Range(20-70)  50.06±1.25  NA  52.27±1.96 
Gender (n, %) 
Male  79(79%)  NA  43(61.43%) 
Female  21(21%)  NA  27(38.57%) 
Lifestyle Factors (n, %) 
Smoking  60(60%)  <0.001**  13(18.57%) 
Family History  66(66%)  <0.01**  26(37.14%) 
Diabetes  39(39%)  <0.01**  12(17.14%) 
Hypertension  67(67%)  <0.001**  23(32.861%) 
Total cholesterol (mg/dl)  Case  p-value  Control 
Group A  162.81±6.23  <0.005  141.78±5.36 
Group B  204.79±10.47  <0.0005  141.78±5.36 
Triglyceride (mg/dl) 
Group A  129.21±8.84  <0.05  149.14±8.185 
Group B  218.63±9.24  <0.0005  149.14±8.185 
LDL (mg/dl) 
Group A  99.65±4.86  <0.0005  78.52±2.50 
Group B  142.33±4.77  <0.0005  78.52±2.50 
HDL (mg/dl) 
Group A  42.57±1.53  NS  44.44±1.29 
Group B  37.31±0.612  <0.0005  44.44±1.29 
VLDL(mg/dl) 
Group A  21.10±1.216  <0.01  26.3±1.82 
Group B  28.92±3.57  NS  26.3±1.82 
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Table: 4. Arsenic content in hair of cardiac cases & control cases 
 
 
 
P was calculated by student t test, *(p<0.01) 
 
Table: 5. Distribution of arsenic level according to different diagnosis cases 
Types of CHD cases  No. of cases  Arsenic (µg/kg) (Mean±S.E.) 
IHD  51  0.8±0.12 
MI  35  1.0±0.39 
UA  14  0.2±0.05 
IHD=Ischemic Heart Disease, MI= Myocardial Infarction, UA=Unstable Angina 
 
Table:6.   Chromosomal study of patient and healthy control 
Type of cases  MI (Mean±S.E.)  CA (Mean±S.E.) 
Patient  4.4±0.21  0.61±0.13** 
Control  5±0.24*  0.23±0.08 
MI=Mitotic Index, CA=Chromosomal Aberration, *p≤0.05, **p≤0.005 
Table: 7. Distribution of Chromosomal study according to differential diagnosis cases  
Types of CHD cases  No. of cases  MI (Mean±S.E.)  CA (Mean±S.E.) 
IHD  51  4.4±0.29  0.435±0.16 
MI  35  4.3±0.3  0.842±0.22 
UA  14  6.3±1.22  0.00 
IHD=Ischemic Heart Disease, MI= Myocardial Infarction, UA=Unstable Angina 
 
DISCUSSION 
 
Around  29.8  million  people  with  CHD  were 
reported in 2000 in India, out of a total estimated 
population of 1.03 billion people, or a nearly 3% 
overall  prevalence
22. 
  Heart  disease  is  a  leading 
cause of illness disability & death in industrialized 
countries
23. The roles of environmental pollution in 
the etiology of different disease was an important 
consideration
24,25.  The  risk  factors  are  family 
history  of  coronary  heart  disease,  smoking, 
hypertension,  and  diabetes  mellitus,  Serum  lipid 
levels comprising of TGL, T.Chol, HDL, LDL, and 
VLDL level were compared between cardiac cases 
and healthy control. Environmental pollution like 
arsenic  exposure  was  also  observed.    There  are 
some toxic compounds e.g. oxides of nitrogen,  
 
sulfur dioxide and suspended particles which are 
involved in air pollution, are powerful pro-oxidants 
that  enhance  the  oxidation  of  lipoproteins;  and 
oxidized  lipoproteins,  particularly  LDL 
cholesterol,  are  powerful  inducers  of 
artherosclerosis
26.  Various  past  studies  indicated 
that smoking is prevalent in coronary heart disease 
patients.  Here,  the  number  of  smokers  were 
significantly higher (p<0.001) in CHD cases than 
in  control.  Presence  of  diabetes  mellitus  and 
hypertension were  significantly  higher  in  cardiac 
cases  than  healthy  control.  Lipid  level 
Triglyceride, total cholesterol and LDL level were 
significantly higher in cardiac cases as compared 
to healthy control. In India, various cases – control 
Arsenic content in hair sample  Arsenic (µg/kg) (Mean±S.E.) 
Patient  0.7±0.2* 
Healthy control  0.2±0.09 
13        De Auley et al.,                                                                                           Int J Med Res Health Sci. 2013:2(1);8-18  
studies  have  reported  a  high  level  of  total 
cholesterol,  Triglycerides,  Low  Density 
Lipoprotein  in  patients  having  Coronary  Heart 
Disease The study of Kumar et al., Wasir et. al., 
Vashist  et.al.  reported  that  level  of  Total 
Cholesterol were 20% - 40% higher in CHD cases 
compared  to  hospital  based  controls  (p  < 
0.05)
27,28,29.  The  result  of  this  study  is  in  good 
agreement  with  the  past  studies.  Some  diet  and 
lifestyle related risk factors were very important in 
increasing  the  CHD  epidemic  in  India
30,31,32. 
Multivariate Logistic Regression Model was used 
to  assess  the  extent  of  risks  of  independent 
variables on CHD. It is observed that the risk of 
CHD significantly increases with increase in serum 
LDL level, hypertension and age.  
Ingested inorganic arsenic has been related to an 
increased  incidence  of  cardiovascular  disease, 
especially  ischemic  heart  disease  and  has  been 
reviewed  extensively
33.  Many  epidemiological 
studies  reported  that  exposure  to  fine  particles 
present  in  ambient  air  is  associated  with  an 
increase  in  cardiovascular  mortality.  Statistically 
significant  relationships  between  particulate  air 
pollution and ischemic heart disease, arrhythmias, 
and  heart  failure  have  been  reported
34.  Carotid 
atherosclerosis  are  associated  with  ingested 
inorganic arsenic, showing a significant biological 
gradient
35.  Zaldivar  reported  several  cases  of 
myocardial  infarction  and  arterial  thickening  in 
children who consumed water containing about 0.6 
mg/l arsenic (1974)
36. 
Two worst arsenic affected areas in the world are 
Bangladesh and West Bengal, India. According to 
WHO guideline the maximum permissible limit for 
arsenic  in  dirking  water  is  below  50µg/L
37. 
Approximately  58%  cases  were  from  above 
10µg/L and 42% cases were from above 50µg/L 
water  arsenic  content  area.  Among  all  types  of 
CHD cases, approximately 80% of MI cases were 
coming from above 50µg/L water arsenic content 
area.  Whereas  only  27.45%  of  IHD  cases  were 
coming from above 50µg/L water arsenic content 
area,  the  rest  of  them  were  from  above  10µg/L 
water arsenic content area. In the human uptake of 
arsenic mainly occurs via the food chain (dietary 
sources  and  drinking  water)  and  occupational 
exposure
38,39.    It  was  found  that  the  arsenic 
concentration of hair of cardiac cases significantly 
(p<0.01)  high  compared  to  healthy  individuals. 
Typical background levels of arsenic in hair are in 
the  range  of  0.08–0.250  μg  g−1  (indicator  for 
toxicity  level  established  at  1  μg  As  g−1)
40.  In 
myocardial  infarction cases  it  was  in  toxic  level 
(1.0±0.39µg/kg).In case of ischemic heart disease 
arsenic  content  is  not  in  toxic  level  but  it  is  in 
alarming  situation  that  is  well  above  the  normal 
range.  Thus  it  can  be  say  that  coronary  heart 
disease cases are having arsenic body burden. Past 
studies in Bangladesh & Spain also reported raised 
mortality  rates  from  cardiovascular  disease 
including hypertension, ischemic heart disease and 
carotid  atherosclerosis  associated  with  arsenic 
exposure
41-47. The entire study samples were from 
West Bengal where both the problems that is an 
occurrence of CHD and ill effects of arsenic are 
found.  Moreover,  very  few  efforts  were  made 
previously  to  find  the  relation  between  them  in 
West Bengal. 
In  our  present  study  some  chromosomal 
aberrations  were  observed.  Patient  showed  about 
2.65 fold increase in chromosomal aberrations as 
compared to controls (Table 6). Among all types of 
stable  chromosomal  aberration  (CA)  found, 
chromatid  break  was  the  main  CA  observed.  A 
decreased  in  the  mean  mitotic  index  (MI)  was 
found  among  the  patients  in  the  study.  This 
suggests a slower progression of the lymphocytes 
from S to M phase of the cell cycles, since every 
popularly  known  clastogens  disturb  the  orderly 
progression of cell division
48. A previous study by 
Chakraborty et al (2006) and Mahata et al (2003) 
explained  that  the  CA  was  significantly  high 
among  the  arsenic  exposed  population  of  West 
Bengal  comparision  with  the  unexposed  healthy 
control group
19,
49. 
Very few studies were reported which stated that 
CA was responsible for CHD. Sajeetha Beegam et 
al.  found  some  chromosomal  aberration  among 
ischemic heart disease patients
50.  CA was higher 
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in MI patients than other types of CHD cases. Most 
of  the  MI  cases  approximately  80%  cases  were 
coming  from  groundwater  arsenic  contaminated 
area. Moreover as per findings above, in the group 
of myocardial infarction both level of hair arsenic 
and chromosomal aberration were high. Therefore 
in  line  with  the  above  discussion,  it  may  be 
interpreted  that  chromosomal  aberration  in 
coronary heart disease cases of West Bengal is due 
to the clastogenic effect of arsenic.  
 
CONCLUSION 
 
It  has  been  observed  through  this study  that  the 
risk  of  CHD  significantly  increases  with  an 
increase  of  serum  LDL  level,  hypertension  and 
age. In India, CHD is one of the most imperative 
reasons  of  death  and  the  scenario  is  not  at  all 
different  in  West  Bengal  too.  Moreover,  West 
Bengal is one of the badly arsenic affected areas of 
India. By studying the hair samples of our CHD 
cases, we found that they were having arsenic body 
burden.  The  clastogenic  effect  of  arsenic  was 
found in the studied cases. In case of MI group, 
water and hair arsenic levels both were high; it also 
showed chromosomal aberration higher than other 
groups. Here, chromosomal aberration played as a 
bio marker for the effect of arsenic on CHD cases 
of West Bengal. This study indicated that ground 
water arsenic contamination of West Bengal might 
have some impact on occurrence of CHD in this 
population.  
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